Literature DB >> 296

Limited hydrolysis of tRNA by phosphodiesterase.

G R Philipps, T Chiemprasert.   

Abstract

Digestion of tRNA by electrophoretically pure phosphodiesterase is limited to a short sequence of nucleotides at the 3'-terminus. On the average, four percent of all nucleotides can be released from tRNA. The optimum Mg2 concentration is 10mM and the optimum pH 9.2. The mode of action is a random attack by the enzyme on the substrate. The terminal AMP is completely removed at 15 degrees C after short incubation; about 400 mol of AMP were removed per min by 1 mol of enzyme. The following CMP residues are released much more slowly; at 15 degrees C incompletely, and at 37 degrees C more or less completely in 1 h. In about 50% of the tRNA molecules, the fourth nucleotide could be removed in very long incubations or with very high enzyme concentrations.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 296     DOI: 10.1515/bchm2.1975.356.2.1097

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  10 in total

1.  Small-bowel diaphragm disease: seven surgical cases.

Authors:  Michael E Kelly; Lisa E McMahon; Dawn E Jaroszewski; Mahmoud M Yousfi; Giovanni De Petris; James M Swain
Journal:  Arch Surg       Date:  2005-12

2.  Histopathology of diaphragm disease of the small intestine: a study of 10 cases from a single institution.

Authors:  Giovanni De Petris; José I López
Journal:  Am J Clin Pathol       Date:  2008-10       Impact factor: 2.493

3.  Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs.

Authors:  J Lang; A B Price; A J Levi; M Burke; J M Gumpel; I Bjarnason
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

Review 4.  Intestinal toxicity of non-steroidal anti-inflammatory drugs.

Authors:  I Bjarnason; A J Macpherson
Journal:  Pharmacol Ther       Date:  1994 Apr-May       Impact factor: 12.310

5.  Clinical and pathologic overlap in nonsteroidal anti-inflammatory drug-related small bowel diaphragm disease and the neuromuscular and vascular hamartoma of the small bowel.

Authors:  G Cortina; S Wren; B Armstrong; K Lewin; L Fajardo
Journal:  Am J Surg Pathol       Date:  1999-11       Impact factor: 6.394

6.  Visible small-intestinal mucosal injury in chronic NSAID users.

Authors:  David Y Graham; Antone R Opekun; Field F Willingham; Waqar A Qureshi
Journal:  Clin Gastroenterol Hepatol       Date:  2005-01       Impact factor: 11.382

Review 7.  Diaphragm disease after use of nonsteroidal anti-inflammatory agents: first report of diagnosis with capsule endoscopy.

Authors:  Mahmoud M Yousfi; Giovanni De Petris; Jonathan A Leighton; Virender K Sharma; Barbara A Pockaj; Dawn E Jaroszewski; Russell I Heigh; Nizar N Ramzan; David E Fleischer
Journal:  J Clin Gastroenterol       Date:  2004-09       Impact factor: 3.062

Review 8.  Determining small bowel integrity following drug treatment.

Authors:  Simon Smale; Ingvar Bjarnason
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

Review 9.  [Gastrointestinal complications related to NSAIDs].

Authors:  Laurent Beaugerie; Gérard Thiéfin
Journal:  Gastroenterol Clin Biol       Date:  2004-04

10.  Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study.

Authors:  Laurence Maiden; Bjarni Thjodleifsson; Anna Seigal; Ingvar Iain Bjarnason; David Scott; Sigurbjorn Birgisson; Ingvar Bjarnason
Journal:  Clin Gastroenterol Hepatol       Date:  2007-07-10       Impact factor: 11.382

  10 in total
  1 in total

Review 1.  Flavonoids Alleviate Peripheral Neuropathy Induced by Anticancer Drugs.

Authors:  Manaal Siddiqui; Basma Abdellatif; Kevin Zhai; Alena Liskova; Peter Kubatka; Dietrich Büsselberg
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.